On December 12|Yingjian Healthcare (01419.HK) issued an announcement. According to the Group's current business data from July 1, 2023 to September 30, 2023, the Group's revenue for the quarter was approximately HK$141.2 million, compared with the Group's revenue of about HK$421.7 million for the same period last year.
The decline in the Group's earnings for the quarter was mainly due to the continued decline in demand and supply of COVID-19 related prevention, testing, vaccination and outreach services, and the reduction in revenue from the Group's general health services.